Our results provide evidence for the impact of common variants on the risk for AML or MDS susceptibility and further characterization of the 6p25.3 locus might provide a more mechanistic basis for the pleiotropic role of IRF4 in AML and MDS susceptibility. Here, IRF4 is linked to myelodysplastic syndrome.